Literature DB >> 30230652

Active site flexibility revealed in crystal structures of Parabacteroides merdae β-glucuronidase from the human gut microbiome.

Michael S Little1, Samantha M Ervin1, William G Walton1, Ashutosh Tripathy2, Yongmei Xu3, Jian Liu3, Matthew R Redinbo1,2,4,5.   

Abstract

β-Glucuronidase (GUS) enzymes in the gastrointestinal tract are involved in maintaining mammalian-microbial symbiosis and can play key roles in drug efficacy and toxicity. Parabacteroides merdae GUS was identified as an abundant mini-Loop 2 (mL2) type GUS enzyme in the Human Microbiome Project gut metagenomic database. Here, we report the crystal structure of P. merdae GUS and highlight the differences between this enzyme and extant structures of gut microbial GUS proteins. We find that P. merdae GUS exhibits a distinct tetrameric quaternary structure and that the mL2 motif traces a unique path within the active site, which also includes two arginines distinctive to this GUS. We observe two states of the P. merdae GUS active site; a loop repositions itself by more than 50 Å to place a functionally-relevant residue into the enzyme's catalytic site. Finally, we find that P. merdae GUS is able to bind to homo and heteropolymers of the polysaccharide alginic acid. Together, these data broaden our understanding of the structural and functional diversity in the GUS family of enzymes present in the human gut microbiome and point to specialization as an important feature of microbial GUS orthologs.
© 2018 The Protein Society.

Entities:  

Keywords:  biological chemistry; carbohydrate-binding protein; enzymology; glycoside hydrolase-2 (GH2); structural biology

Mesh:

Substances:

Year:  2018        PMID: 30230652      PMCID: PMC6237702          DOI: 10.1002/pro.3507

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  43 in total

1.  Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular conjugate export pump (Mrp2).

Authors:  S Seitz; A Kretz-Rommel; R P Oude Elferink; U A Boelsterli
Journal:  Chem Res Toxicol       Date:  1998-05       Impact factor: 3.739

Review 2.  Biosynthesis of glycosaminoglycans: associated disorders and biochemical tests.

Authors:  Florin Sasarman; Catalina Maftei; Philippe M Campeau; Catherine Brunel-Guitton; Grant A Mitchell; Pierre Allard
Journal:  J Inherit Metab Dis       Date:  2015-12-21       Impact factor: 4.982

Review 3.  Glucuronides in the gut: Sugar-driven symbioses between microbe and host.

Authors:  Samuel J Pellock; Matthew R Redinbo
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

4.  The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in vivo.

Authors:  Michael A Malfatti; Esther A Ubick; James S Felton
Journal:  Carcinogenesis       Date:  2005-06-08       Impact factor: 4.944

5.  Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.

Authors:  Michael A Malfatti; James S Felton
Journal:  Chem Res Toxicol       Date:  2004-08       Impact factor: 3.739

6.  Microbial Glucuronidase Inhibition Reduces Severity of Diclofenac-Induced Anastomotic Leak in Rats.

Authors:  Simon T K Yauw; Melissa Arron; Roger M L M Lomme; Petra van den Broek; Rick Greupink; Aadra P Bhatt; Matthew R Redinbo; Harry van Goor
Journal:  Surg Infect (Larchmt)       Date:  2018-04-06       Impact factor: 2.150

7.  An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.

Authors:  Rebecca M Pollet; Emma H D'Agostino; William G Walton; Yongmei Xu; Michael S Little; Kristen A Biernat; Samuel J Pellock; Loraine M Patterson; Benjamin C Creekmore; Hanna N Isenberg; Rohini R Bahethi; Aadra P Bhatt; Jian Liu; Raad Z Gharaibeh; Matthew R Redinbo
Journal:  Structure       Date:  2017-06-01       Impact factor: 5.006

8.  Towards automated crystallographic structure refinement with phenix.refine.

Authors:  Pavel V Afonine; Ralf W Grosse-Kunstleve; Nathaniel Echols; Jeffrey J Headd; Nigel W Moriarty; Marat Mustyakimov; Thomas C Terwilliger; Alexandre Urzhumtsev; Peter H Zwart; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-03-16

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.

Authors:  Bret D Wallace; Adam B Roberts; Rebecca M Pollet; James D Ingle; Kristen A Biernat; Samuel J Pellock; Madhu Kumar Venkatesh; Leah Guthrie; Sara K O'Neal; Sara J Robinson; Makani Dollinger; Esteban Figueroa; Sarah R McShane; Rachel D Cohen; Jian Jin; Stephen V Frye; William C Zamboni; Charles Pepe-Ranney; Sridhar Mani; Libusha Kelly; Matthew R Redinbo
Journal:  Chem Biol       Date:  2015-09-10
View more
  6 in total

1.  Functional metagenomic screening identifies an unexpected β-glucuronidase.

Authors:  Stefanie Neun; Paul Brear; Eleanor Campbell; Theodora Tryfona; Kamel El Omari; Armin Wagner; Paul Dupree; Marko Hyvönen; Florian Hollfelder
Journal:  Nat Chem Biol       Date:  2022-07-07       Impact factor: 16.174

2.  Characterizing the metabolic effects of the selective inhibition of gut microbial β-glucuronidases in mice.

Authors:  Marine P M Letertre; Aadra P Bhatt; Michael Harvey; Jeremy K Nicholson; Ian D Wilson; Matthew R Redinbo; Jonathan R Swann
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

3.  Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens.

Authors:  Samantha M Ervin; Hao Li; Lauren Lim; Lee R Roberts; Xue Liang; Sridhar Mani; Matthew R Redinbo
Journal:  J Biol Chem       Date:  2019-10-21       Impact factor: 5.486

4.  Towards a 'chassis' for bacterial magnetosome biosynthesis: genome streamlining of Magnetospirillum gryphiswaldense by multiple deletions.

Authors:  Theresa Zwiener; Marina Dziuba; Frank Mickoleit; Christian Rückert; Tobias Busche; Jörn Kalinowski; René Uebe; Dirk Schüler
Journal:  Microb Cell Fact       Date:  2021-02-04       Impact factor: 5.328

5.  Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes.

Authors:  Moamen M Elmassry; Sunghwan Kim; Ben Busby
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

6.  Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy.

Authors:  Aadra P Bhatt; Samuel J Pellock; Kristen A Biernat; William G Walton; Bret D Wallace; Benjamin C Creekmore; Marine M Letertre; Jonathan R Swann; Ian D Wilson; Jose R Roques; David B Darr; Sean T Bailey; Stephanie A Montgomery; Jeffrey M Roach; M Andrea Azcarate-Peril; R Balfour Sartor; Raad Z Gharaibeh; Scott J Bultman; Matthew R Redinbo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-13       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.